Shyler Demill, DO
Foot and Ankle Surgery · Yakima, WANPI 1942499975
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,018 of the $25,979 with a category attached, or 77.1%. Paragon 28, Inc. accounts for 96.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $15,553 and has fallen 92.5% since, to $1,171 in 2025. Among foot and ankle surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $472.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$25K
- Heron Therapeutics, Inc.$195
- Smith+Nephew$156
- Stryker$99
- Parcus Medical, LLC$96
- Johnson & Johnson$94
- plus $259 from 7 others
What the payments were for
- Consulting fees$20,01877%
- Travel & lodging$4,27216%
- Food & beverage$1,6907%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 26 | $25,080 |
| Heron Therapeutics, Inc. | 4 | $195 |
| Smith+Nephew | 2 | $156 |
| Stryker(2 entities) | 5 | $99 |
| Parcus Medical, LLC | 1 | $96 |
| Johnson & Johnson | 4 | $94 |
| Linvatec Corporation | 1 | $82 |
| Orthofix Medical, Inc. | 5 | $37 |
| Ossio Inc | 2 | $33 |
| Anika Therapeutics, Inc. | 1 | $32 |
| Amniox Medical, Inc. | 2 | $29 |
| Active Medical, LLC | 1 | $26 |
| Treace Medical Concepts, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$21,394
- Product Portfolio$2,295
- APEX 3D$962
- PSI$140
- TRIGEN InterTAN$129
How this compares
$25,979 in reported general payments places this provider in the 90th percentile of 203 foot and ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 78 | $487 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $352 |
| Meloxicam | 109 | $234 |
| Tramadol Hcl | 87 | $225 |
| Gabapentin | 74 | $210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $209 |
| Cephalexin | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Yakima
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
- Garrett PereskoMorton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.